Salix to be Discussed on's Talkin' Horses

The controversial subject of furosemide, the anti-bleeder medication widely used in North American horse racing, will be the subject of the next "Talkin' Horses with The Blood-Horse" live podcast at 2 p.m. EDT, June 26 on

During the podcast, the medication marketed under the trade name Salix (formerly known as Lasix) will be discussed by J. David Richardson, MD, and Foster Northrop, DVM. The podcast will be moderated by Tom LaMarra, news editor of The Blood-Horse magazine and, and Ron Mitchell, online managing editor at

Richardson is chairman of the Thoroughbred Owners and Breeders Association's American Graded Stakes Committee (AGSC) and a member of the Breeders' Cup board of members. The AGSC has endorsed a race-day ban on Salix in graded stakes for 2-year-olds and Breeders' Cup intends to ban race-day Salix in its 2-year-old World Championships stakes this fall.

Richardson will be followed on the podcast by Northrop, a racetrack veterinarian and member of the Kentucky Horse Racing Commission (KHRC). Northrop voted against the KHRC's recent approval of an administrative regulation that would ban the use of furosemide on race-day in graded and listed stakes over a three-year period beginning Jan. 1, 2014.

Deadline to submit questions for this edition of "Talkin' Horses with The Blood-Horse" is 5 p.m. EDT on June 25, by one of the following ways: Tweet questions to using #TalkinHorses; post questions via; or email questions to

All live broadcasts of "Talkin' Horses with The Blood-Horse" will be recorded and archived for on-demand listening on Visitors can listen to archived episodes directly or download episodes individually.

About the Author

The Blood-Horse Staff

The Blood-Horse is the leading weekly publication devoted to international Thoroughbred racing and breeding. Since 1916, the staff of The Blood-Horse has served the Thoroughbred community with the highest standards of journalistic excellence to provide comprehensive and timely editorial coverage and analysis.

Stay on top of the most recent Horse Health news with FREE weekly newsletters from Learn More

Free Newsletters

Sign up for the latest in:

From our partners